Skip to main content

Table 1 Resource and costing: data sources (updated to 2011 prices)

From: Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison

Data

Cost (€)

Source

Annualised cost of outpatient care (based on Spanish data from 2002)

2058.60

Bobes et al., 2004 [30]

Inpatient cost of relapse management based on 2000 Spanish data

4226.91

Peiró et al., [31]

Outpatient cost of relapse management based on 2000 Spanish data (42.94% of inpatient cost)

884.38

Peiró et al., [31]

Cost of switching treatment (assumed at three times the routine cost of schizophrenia management = 3 × €5.64)

16.92/day

Bobes et al., 2004 [30]

NICE (2009) [32]

Cost associated with post-injection syndrome management, assuming 3 days of additional inpatient hospitalisation (€157.00), one additional day in an emergency psychiatric ward (€107.90) and one additional visit to a psychiatrist (€62.10) = €327.00 based on 2005 costs

368.53

Bernardo et al., 2006 [33]

Cost of administration: OLAI, based on a nurse visit cost of €24.56 plus 3 hours observation time for a group of 8 patients at €10.21

34.77

http://www.oblikue.com/bddcostes/

Cost of administration: RLAI based on a nurse visit cost of €24.56

24.56

http://www.oblikue.com/bddcostes/